Three insights:
1. The device was shown to increase the lumbar spinal fusion group’s success rate from 75 percent to 92 percent without the use of bone morphogenetic protein in its peer-reviewed clinical testing.
2. KG 1 has more than doubled the inside dimension of traditional funnels, bi-portal ejection zones for better graft fill volume, a removable funnel cup and a wedged tip with a radiographic marker.
3. The device’s rectangular shape and size leaves an optimum void upon removal, which helps surgeons introduce a fusion cage.
More articles on devices:
Stryker expands overseas & more: 6 device company notes
FDA clears new minimally invasive Life Spine device
New View Surgical closes $2.5M funding round — 3 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
